Advertisement
For patients with papillary thyroid cancer

Patient Age Linked to Survival in Papillary Thyroid Cancer

0
Linear reduction in cancer-specific survival with increasing age, with no evidence of a cut point

October 2016 Briefing – Surgery

0
Here are what the editors at HealthDay consider to be the most important developments in Surgery for October 2016. This roundup includes the latest...
Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014

Few Changes in Employer-Sponsored Insurance 2013-2014

0
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
Older breast cancer patients who have undergone mastectomy benefit as much as younger women from breast reconstruction

Older, Younger Women Equally Benefit From Breast Recon

0
No greater risk of complications for older patients; benefited as much as younger breast cancer patients

North American Spine Society, Oct. 26-29

0
The North American Spine Society 31st Annual Meeting The annual meeting of the North American Spine Society was held from Oct. 26 to...
For patients with left main coronary artery disease

PCI Noninferior to CABG for Left Main Coronary Artery Disease

0
PCI with everolimus-eluting stent noninferior for composite of death, stroke, or MI at three years
After Roux-en-Y gastric bypass surgery

Study Duration Affects Rate of Diabetes Remission Post-RYGB

0
Differing definitions of remission also account for varied reported remission rates after gastric bypass
In an article published in Medical Economics

Useful Tips Offered for Addressing Negative Patient Reviews

0
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
Mohs micrographic surgery is efficacious for melanoma in situ (MIS) on the trunk and proximal extremities

Mohs Effective for Melanoma in Situ of Trunk, Extremities

0
Surgical margin of 9 mm needed to excise 97 percent of melanoma in situ
The side of origin of colon cancer impacts prognosis

Review: Reduced Risk of Death for Left-Sided Colon Cancer

0
Significantly reduced risk of death, independent of confounding variables, including stage, race, chemo